These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 7575515

  • 1. Orally active and long-term acting insulin-mimetic vanadyl complex:bis(picolinato)oxovanadium (IV).
    Sakurai H, Fujii K, Watanabe H, Tamura H.
    Biochem Biophys Res Commun; 1995 Sep 25; 214(3):1095-101. PubMed ID: 7575515
    [Abstract] [Full Text] [Related]

  • 2. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities.
    Yamaguchi M, Wakasugi K, Saito R, Adachi Y, Yoshikawa Y, Sakurai H, Katoh A.
    J Inorg Biochem; 2006 Feb 25; 100(2):260-9. PubMed ID: 16387366
    [Abstract] [Full Text] [Related]

  • 3. Novel vanadyl complexes with quinoxaline N(1),N(4)-dioxide derivatives as potent in vitro insulin-mimetic compounds.
    Noblía P, Vieites M, Torre MH, Costa-Filho AJ, Cerecetto H, González M, Lavaggi ML, Adachi Y, Sakurai H, Gambino D.
    J Inorg Biochem; 2006 Feb 25; 100(2):281-7. PubMed ID: 16386797
    [Abstract] [Full Text] [Related]

  • 4. An orally active antidiabetic vanadyl complex, bis(1-oxy-2-pyridinethiolato)oxovanadium(IV), with VO(S2O2) coordination mode; in vitro and in vivo evaluations in rats.
    Sakurai H, Sano H, Takino T, Yasui H.
    J Inorg Biochem; 2000 May 30; 80(1-2):99-105. PubMed ID: 10885469
    [Abstract] [Full Text] [Related]

  • 5. Structure-dependent metallokinetics of antidiabetic vanadyl-picolinate complexes in rats: studies on solution structure, insulinomimetic activity, and metallokinetics.
    Yasui H, Tamura A, Takino T, Sakurai H.
    J Inorg Biochem; 2002 Jul 25; 91(1):327-38. PubMed ID: 12121792
    [Abstract] [Full Text] [Related]

  • 6. A new orally active antidiabetic vanadyl complex--bis(alpha-furancarboxylato)oxovanadium(IV).
    Xie M, Gao L, Li L, Liu W, Yan S.
    J Inorg Biochem; 2005 Feb 25; 99(2):546-51. PubMed ID: 15621288
    [Abstract] [Full Text] [Related]

  • 7. [Insulino-mimetic effects of bis (alpha-furancarboxylato) oxovanadium (IV) in vitro].
    Li YR, Gao LH, Ma YL, Niu YF, Liu WP, Li L.
    Yao Xue Xue Bao; 2008 Mar 25; 43(3):318-22. PubMed ID: 18630272
    [Abstract] [Full Text] [Related]

  • 8. Bis(6-ethylpicolinato)oxovanadium(IV) complex with normoglycemic activity in KK-A(y) mice.
    Sasagawa T, Yoshikawa Y, Kawabe K, Sakurai H, Kojima Y.
    J Inorg Biochem; 2002 Jan 01; 88(1):108-12. PubMed ID: 11750032
    [Abstract] [Full Text] [Related]

  • 9. A new halogenated antidiabetic vanadyl complex, bis(5-iodopicolinato)oxovanadium(IV): in vitro and in vivo insulinomimetic evaluations and metallokinetic analysis.
    Takino T, Yasui H, Yoshitake A, Hamajima Y, Matsushita R, Takada J, Sakurai H.
    J Biol Inorg Chem; 2001 Feb 01; 6(2):133-42. PubMed ID: 11293406
    [Abstract] [Full Text] [Related]

  • 10. The antilipolytic action of bis(alpha-furancarboxylato)oxovanadium(IV) in adipocytes.
    Gao L, Niu Y, Liu W, Xie M, Liu X, Chen Z, Li L.
    Clin Chim Acta; 2008 Feb 01; 388(1-2):89-94. PubMed ID: 17991430
    [Abstract] [Full Text] [Related]

  • 11. Hypoglycemic effect of macrocyclic binuclear oxovanadium (IV) complex on streptozotocin-induced diabetic rats.
    Ramachandran B, Sekar DS, Kandaswamy M, Narayanan V, Subramanian S.
    Exp Diabesity Res; 2004 Feb 01; 5(2):137-42. PubMed ID: 15203884
    [Abstract] [Full Text] [Related]

  • 12. Possible mode of action for insulinomimetic activity of vanadyl(IV) compounds in adipocytes.
    Kawabe K, Yoshikawa Y, Adachi Y, Sakurai H.
    Life Sci; 2006 May 08; 78(24):2860-6. PubMed ID: 16337244
    [Abstract] [Full Text] [Related]

  • 13. Insulinomimetic bis(maltolato)zinc(II) complex: blood glucose normalizing effect in KK-A(y) mice with type 2 diabetes mellitus.
    Yoshikawa Y, Ueda E, Miyake H, Sakurai H, Kojima Y.
    Biochem Biophys Res Commun; 2001 Mar 08; 281(5):1190-3. PubMed ID: 11243860
    [Abstract] [Full Text] [Related]

  • 14. Anti-diabetic effects of vanadium(III, IV, V)-chlorodipicolinate complexes in streptozotocin-induced diabetic rats.
    Li M, Ding W, Smee JJ, Baruah B, Willsky GR, Crans DC.
    Biometals; 2009 Dec 08; 22(6):895-905. PubMed ID: 19404749
    [Abstract] [Full Text] [Related]

  • 15. A novel drug delivery system for type 1 diabetes: insulin-mimetic vanadyl-poly(gamma-glutamic acid) complex.
    Karmaker S, Saha TK, Yoshikawa Y, Yasui H, Sakurai H.
    J Inorg Biochem; 2006 Sep 08; 100(9):1535-46. PubMed ID: 16824605
    [Abstract] [Full Text] [Related]

  • 16. Insulin-mimetic vanadyl(IV) complexes as evaluated by both glucose-uptake and inhibition of free fatty acids (FFA)-release in isolated rat adipocytes.
    Adachi Y, Sakurai H.
    Chem Pharm Bull (Tokyo); 2004 Apr 08; 52(4):428-33. PubMed ID: 15056957
    [Abstract] [Full Text] [Related]

  • 17. Bis(allixinato)oxovanadium(IV) complex is a potent antidiabetic agent: studies on structure-activity relationship for a series of hydroxypyrone-vanadium complexes.
    Adachi Y, Yoshida J, Kodera Y, Katoh A, Takada J, Sakurai H.
    J Med Chem; 2006 Jun 01; 49(11):3251-6. PubMed ID: 16722643
    [Abstract] [Full Text] [Related]

  • 18. Antidiabetic activity of the orally effective vanadyl-poly (gamma-glutamic acid) complex in streptozotocin(STZ)-induced type 1 diabetic mice.
    Karmaker S, Saha TK, Sakurai H.
    J Biomater Appl; 2008 Mar 01; 22(5):449-64. PubMed ID: 17494957
    [Abstract] [Full Text] [Related]

  • 19. Insulin-like effects of bis-glycinato oxovanadium (IV) complex on experimental diabetic rats.
    Nandhini D, Maneemegalai S, Elangovan V, Sekar N, Govindasamy S.
    Indian J Biochem Biophys; 1993 Feb 01; 30(1):73-6. PubMed ID: 8509129
    [Abstract] [Full Text] [Related]

  • 20. Insulin-enhancing activity of a dinuclear vanadium complex: 5-chloro-salicylaldhyde ethylenediamine oxovanadium(V) and its permeability and cytotoxicity.
    Xie MJ, Yang XD, Liu WP, Yan SP, Meng ZH.
    J Inorg Biochem; 2010 Aug 01; 104(8):851-7. PubMed ID: 20434776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.